findmyKOL

Vijayakumar Javalkar, MBBS

Basic profile

Louisiana State University in Shreveport

ORCIDNone on fileNPI
RegionShreveport, LA · South CentralSpecialtyVascular NeurologyFocusNeurology
Active KOLfindmyKOL typefindmyKOL type: our influence ranking, shown when you reveal the full profileLatest publication2024Online presenceNot yet checkedPayments2021 onwardNIH fundingNot yet indexedWhy? →

Vijayakumar Javalkar is a Neurology physician affiliated with Louisiana State University in Shreveport. OpenAlex indexes 60 publications with 1,050 citations (h-index 18).

Overview

Scholarship

indexed output and impact (OpenAlex)
View publications ↓
60publications

Distinct works indexed by OpenAlex.

1,050citations

Total citations across indexed works.

18h-index

Hirsch index, productivity × impact (OpenAlex).

Clinical & industry

trials, payments and federal funding
31companies · 2021 onward

Companies reporting payments to CMS. Facts, not judgments.

View payments

Contact

The practice address and phone this provider lists in the federal NPPES (CMS) registry.

Practice address

1541 Kings Hwy
Shreveport, LA 711034228

Telephone

318-626-0000

Provider last certified this registry record 11 Mar 2024.

View the NPPES registry record

Industry payments

31 companies reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:

View the CMS Open Payments record ↗

Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward.

Medicare prescribing footprint (2024)

The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.

  • Nervous system

    86.8%
    Aromatic Amino Acid Decarboxylation Inhibitor36.3%
    Carbidopa-Levodopa57%Carbidopa-Levodopa Er23%Carbidopa-Levodopa-Entacapone12%Rytary7%
    Part D<11 patients
    Monoamine Oxidase Inhibitor12.5%
    Rasagiline Mesylate61%Selegiline Hcl39%
    Part D<11 patients

    + 9 more classes in this area

  • Cardiovascular

    6.4%
    Statin6.4%
    Atorvastatin Calcium100%
    Part D15 patients
  • Musculoskeletal

    4.4%
    gamma-Aminobutyric Acid-ergic Agonist4.4%
    Baclofen100%
    Part D<11 patients
Where care is delivered (Part B)34.9% facility · 65.1% office

Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.

Publications

Matched to this physician's OpenAlex author record; most-cited works shown first.

Similar KOLs

Other experts from the same institution or the same specialty.

A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments — shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”